Amani Abdel Nabey Hafez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amani Abdel Nabey Hafez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Abeer Mostafa Abdalhamed
Department of Parasitology and Animal Diseases, National Research Centre, Dokki, Egypt
1 shared publication - Amany Ahmed Arafa
Department of Microbiology and Immunology, National Research Centre, Dokki, Egypt
1 shared publication - Doaa Sedky
Department of Parasitology and Animal Diseases, National Research Centre, Veterinary Research Institute, Giza, Egypt
1 shared publication - Eman Shafeek Ibrahim
Department of Microbiology and Immunology, National Research Centre, Dokki, Giza, Egypt
1 shared publication - Gamil Sayed Gamil Zeedan
Parasitology and Animals Diseases Department, National Research Centre, 33 Bohouth Street, Dokki, 12622, Giza, Egypt
1 shared publication
Latest Publications
- Open Access
- 22 November 2022
- Published by Wiley in Veterinary Medicine International
- Vol. 2022, 1-14
Detection of Methicillin-Resistant Staphylococcus aureus in Clinical and Subclinical Mastitis in Ruminants and Studying the Effect of Novel Green Synthetized Nanoparticles as One of the Alternative Treatments
Mastitis is an important disease in dairy animals worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of clinical and subclinical intramammary infections. In the current study, we isolated bacteria from 150 mastitic milk samples. Multiplex PCR was used to detect the methicillin resistance genes in S. aureus to detect the occurrence of MRSA isolates. Green synthesized titanium dioxide nanoparticles (TiO2 NPs) using aqueous leaf extracts of Artemisia herb Alba (A. herb Alba TiO2 NPs). The antibacterial efficacy of these nanoparticles was evaluated (in vitro and in vivo) against collected MRSA isolates using the disc diffusion method and SPF rats. Out of 150 mastitic milk samples, the frequency of S. aureus was 38 (25.3), that of E. coli was 45 (30), that of Klebsiella spp. Was 7 (4.7), and that of Streptococcus spp. Was 11 (7.3). Among 38 positive isolates of S. aureus, MRSA was 16 (42.1) by antimicrobial sensitivity testing (AST) and 14 (38.8) by multiplex PCR. The MRSA isolates were shown to have 100 resistance to penicillin and methicillin, 87.5 resistance to gentamicin, 50 resistance to cefoxitin and amoxicillin, and 75 resistance to ampicillin and ampicillin/sublactam with low resistance against erythromycin, ciprofloxacin, tetracycline, and levofloxacin by AST, respectively. A. herb Alba TiO2 NP formation was observed by changing the colour from white to dark green. The UV spectrum revealed absorbance peaks at 240250nm, and their sizes ranged from 4266nm and 11 to 45nm by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). A. herb Alba TiO2 NP suspensions were evaluated against MRSA, with the highest zone of inhibition (43±0.45mm) at a concentration of 40μg/ml. Hematological parameters and histological examination after oral administration of 20mg/kg of A. herb Alba TiO2 NPs indicated that A. herb Alba TiO2 NPs can be used as a new antimicrobial against resistant bacteria (MRSA) with consideration of the dose and methods of synthesis of plant-based compounds.
- 22 November 2022
- Published by Wiley in Veterinary Medicine International
- Vol. 2022, 1-14
Open AccessDetection of Methicillin-Resistant Staphylococcus aureus in Clinical and Subclinical Mastitis in Ruminants and Studying the Effect of Novel Green Synthetized Nanoparticles as One of the Alternative Treatments
Mastitis is an important disease in dairy animals worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of clinical and subclinical intramammary infections. In the current study, we isolated bacteria from 150 mastitic milk samples. Multiplex PCR was used to detect the methicillin resistance genes in S. aureus to detect the occurrence of MRSA isolates. Green synthesized titanium dioxide nanoparticles (TiO2 NPs) using aqueous leaf extracts of Artemisia herb Alba (A. herb Alba TiO2 NPs). The antibacterial efficacy of these nanoparticles was evaluated (in vitro and in vivo) against collected MRSA isolates using the disc diffusion method and SPF rats. Out of 150 mastitic milk samples, the frequency of S. aureus was 38 (25.3), that of E. coli was 45 (30), that of Klebsiella spp. Was 7 (4.7), and that of Streptococcus spp. Was 11 (7.3). Among 38 positive isolates of S. aureus, MRSA was 16 (42.1) by antimicrobial sensitivity testing (AST) and 14 (38.8) by multiplex PCR. The MRSA isolates were shown to have 100 resistance to penicillin and methicillin, 87.5 resistance to gentamicin, 50 resistance to cefoxitin and amoxicillin, and 75 resistance to ampicillin and ampicillin/sublactam with low resistance against erythromycin, ciprofloxacin, tetracycline, and levofloxacin by AST, respectively. A. herb Alba TiO2 NP formation was observed by changing the colour from white to dark green. The UV spectrum revealed absorbance peaks at 240250nm, and their sizes ranged from 4266nm and 11 to 45nm by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). A. herb Alba TiO2 NP suspensions were evaluated against MRSA, with the highest zone of inhibition (43±0.45mm) at a concentration of 40μg/ml. Hematological parameters and histological examination after oral administration of 20mg/kg of A. herb Alba TiO2 NPs indicated that A. herb Alba TiO2 NPs can be used as a new antimicrobial against resistant bacteria (MRSA) with consideration of the dose and methods of synthesis of plant-based compounds.
- 25 June 2022
- Published by Scienceline Publication in World's Veterinary Journal
- p. 186-196
Antimicrobial Resistance and Virulence Genes of Campylobacter jejuni Isolates from Diarrheic Sheep
One of the important agents causing gastroenteritis worldwide is Campylobacter jejuni (C. jejuni). The current study aimed to detect five virulence genes (flaA, virB11, ciaB, iam, and dnaJ) and two antibiotic resistance genes (gyrA and tetO) in C. jejuni obtained from sheep stool. The virulence genes were detected by PCR in 64 C. jejuni strains. The phenotypic resistance to five selected antibiotics (Ciprofloxacin, Erythromycin, Gentamycin, Streptomycin, and Tetracycline) was screened with the microdilution method. The isolates with antibiograms were tested for detection of gyrA and tetO genes via PCR using specific primers. The virulence genes flaA (32%) and dnaJ (29%) had the highest prevalence. The tested isolates of C. jejuni revealed high resistance to both quinolone (68.3%) and tetracycline groups (48.4%) with an increased prevalence of antibiotic resistance of gyrA and tetO genes. Gentamycin and erythromycin offered better alternative drugs for the treatment of campylobacteriosis. To generalize the findings, extensive profiling that involves more virulence genes is required in several strains of Campylobacter.
- 25 June 2022
- Published by Scienceline Publication in World's Veterinary Journal
- p. 186-196
Antimicrobial Resistance and Virulence Genes of Campylobacter jejuni Isolates from Diarrheic Sheep
One of the important agents causing gastroenteritis worldwide is Campylobacter jejuni (C. jejuni). The current study aimed to detect five virulence genes (flaA, virB11, ciaB, iam, and dnaJ) and two antibiotic resistance genes (gyrA and tetO) in C. jejuni obtained from sheep stool. The virulence genes were detected by PCR in 64 C. jejuni strains. The phenotypic resistance to five selected antibiotics (Ciprofloxacin, Erythromycin, Gentamycin, Streptomycin, and Tetracycline) was screened with the microdilution method. The isolates with antibiograms were tested for detection of gyrA and tetO genes via PCR using specific primers. The virulence genes flaA (32%) and dnaJ (29%) had the highest prevalence. The tested isolates of C. jejuni revealed high resistance to both quinolone (68.3%) and tetracycline groups (48.4%) with an increased prevalence of antibiotic resistance of gyrA and tetO genes. Gentamycin and erythromycin offered better alternative drugs for the treatment of campylobacteriosis. To generalize the findings, extensive profiling that involves more virulence genes is required in several strains of Campylobacter.